ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,009, issued on May 13, was assigned to APGEN THERAPUETICS AB (Sollentuna, Sweden).
"Immunogenic composition for the treatment of cancer" was invented by Jeroen Melief (Sollentuna, Sweden) and Rolf Valter Rikard Kiessling (Stockholm).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of immunotherapy, more in particular to a composition for use in the treatment of cancer. The invention also relates to a composition obtainable by such a method, such as a pharmaceutical composition. More in particular, the invention relates to an ex vivo method for obtaining a composition suitable for the treatment of cancer in a subject, ...